Search results
Body
Showing 311-320 of 345 results
A commonly used anti-anginal drug reduces chest pain in patients with type 2 diabetes and appears to have a greater effect in those with poor glucose control, according to research led by Saint Luke’s Mid America Heart Institute cardiologist Mikhail Kosiborod, M.D.
This is a recognition of the top-performing home health agencies in the United States. Saint Luke’s Home Care and Hospice has received this recognition eight times in the past nine years.
KANSAS CITY, Mo. (May 5, 2014) — Saint Luke’s Mid America Heart Institute interventional cardiologists are on the forefront of perfecting new minimally invasive approaches to treat chronic
Saint Luke’s Hospital of Kansas City has received the American Heart Association/American Stroke Association’s Get With The Guidelines
Saint Luke’s Health System has earned 2021 CHIME Digital Health Most Wired recognition as a certified Ambulatory Level 8 and Acute Level 8.
Saint Luke’s East Hospital achieved accreditation as a Center of Excellence in Specialized Prostate Treatment (COESPT) by Surgical Review Corporation (SRC) for a second consecutive year.
Before his heart transplant, Robert Johnson had a hard time even cutting his grass. Now, after receiving a heart transplant at Saint Luke's Mid America Heart Institute, he is back to enjoying physical activities, like golf.
Saint Luke’s Health System of Kansas City, Mo., BJC HealthCare of St. Louis, Mo., CoxHealth of Springfield, Mo., and Memorial Health System of Springfield, Ill., today announced they have partnered together to create The BJC Collaborative, L.L.C.
DEFINE-HF was not only the first multi-center randomized placebo-controlled clinical trial that Saint Luke’s developed, coordinated, and implemented in its entirety, but the first significant effort to look at what effect dapagliflozin, a drug initially created for the treatment of diabetes, was going to have in patients who also have heart failure.